NEFL and Alzheimer disease: In this prospective cohort study of Japanese older residents without dementia, lower plasma Aβ42/40 levels and higher plasma p‐τ181 levels were significantly associated with an increased risk of AD but not non‐AD, whereas significant associations were observed between higher plasma GFAP and NfL levels and risk of developing both AD and non‐AD.